CNB Financial Corporation Q1 2026 Earnings: Revenue Misses $83.3 Million

CNB Financial Corporation (CCNE) reported Q1 2026 diluted EPS of $0.88, beating estimates, but revenue of $83.3M missed expectations. Net income rose to $26M from $10.4M YoY. Shares were up 0.89% post-earnings. The company attributed growth to its 2025 ESSA acquisition, but noted sequential revenue decline due to commercial real estate payoffs.

Original reporting
Published Sep 15, 2026, 8:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CNB Financial Corporation Q1 2026 Earnings: Revenue Misses $83.3 Million — source image
Decision brief

The 30-second read

$CCNENeutralMed
01

Why it matters

The earnings release provides the first public disclosure of Q1 2026 financials, highlighting an EPS beat and revenue shortfall, which may influence short-term trading decisions.

02

Market read

Earnings beat offers a modest bullish trigger, but revenue miss and loan declines introduce downside risk.

03

What to watch

ESSA acquisition synergies and lower noninterest expense growth could boost future earnings.

Relevance 7/10Novelty 8/10Timing: post-earnings release

Background

CNB Financial (CCNE) is a regional bank with $1B market cap, recently expanded via the 2025 ESSA Bancorp acquisition.

Company-level read

Ticker impact

$CCNENeutralMedium confidence
Context

Q1 2026 earnings beat EPS estimate but missed revenue, shares up 0.89% on release.

Expected impact

modest upside of 2-3% if market focuses on EPS beat, downside risk if revenue concerns dominate

Evidence & confidence

EPS beat is a positive catalyst, but revenue miss and sequential loan decline temper enthusiasm.

Market effects

Regional banking sector may see similar pressure on loan growth and revenue guidance.

Pennsylvania and Mid-Atlantic banking stocks could experience modest volatility.

Limited; primarily a US regional bank story.

Counterpoint

Revenue miss may be overstated; focus on improving efficiency ratio and higher net interest margin.

Key entities

  • Michael Peduzzi

    President & CEO of CNB Financial, provided commentary on earnings.

Related articles

$CCNEMedAI 8/10

Raymond James raises CNB Financial stock price target on fee strength

Raymond James raised its price target for CNB Financial (CCNE) to $40, citing strong Q3 results with fees, operating expenses, and net interest margin beating expectations. Earnings per share were $0.91, exceeding estimates. The stock is up 38% YTD. Analysts note CCNE trades at a discount to peers, with a P/E of 10.63 and PEG of 0.14, suggesting undervaluation. Piper Sandler also initiated coverage with an overweight rating and $38 target.

$CCNEHigh

CNB FINANCIAL CORPORATION REPORTS THIRD QUARTER 2026 RESULTS

CNB FINANCIAL CORP/PA (CCNE) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Contact: Tito L. Lima Treasurer (814) 765-9621 FOR IMMEDIATE RELEASE CNB FINANCIAL CORPORATION REPORTS THIRD QUARTER 2026 RESULTS Clearfield, Pennsylvania – October 21, 2026 CNB Financial Corporation (“Corporation”) (NASDAQ: CCNE), the parent company of CNB Bank, tod

$CCNEMed

CNB FINANCIAL CORPORATION REPORTS SECOND QUARTER 2026 RESULTS

CNB FINANCIAL CORP/PA (CCNE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ccne7-23x2699x1.htm EX-99.1 Document News Release Contact: Tito L. Lima Treasurer (814) 765-9621 FOR IMMEDIATE RELEASE CNB FINANCIAL CORPORATION REPORTS SECOND QUARTER 2026 RESULTS Clearfield, Pennsylvania – July 23, 2026 CNB Financial Corporation (“Corporation”) (NASDA

$MRCYMed

Mercury Systems 3Q 2026: Revenue $253.15M, EPS $0.21 — 10-Q Summary

Mercury Systems reported 3Q 2026 revenue of $253.15M, up 12.4% YoY, and net income of $13.09M, reversing a prior-year loss. Growth in radar and electronic warfare applications drove results, while C4I revenue declined. Gross margin improved to 35.2% from 27.9%. The company expects to recognize 46% of its $1.193B remaining performance obligations as revenue in the next 12 months.

$SNWVMed

Sanuwave Announces Q3 FY2026 Financial Results

SANUWAVE Health, Inc. (SNWV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sanuwave Announces Q3 FY2026 Financial Results Q3 2026 revenues were $8.6 million, down 24% from $11.3 million in Q3 2025. Q3 2026 gross margin was 77.3%, versus 77.6% in Q3 2025. GAAP operating loss was $1.1 million for Q3 2026 versus operating income of $0.9 millio

$CPIXHighAI 8/10

CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS INC (CPIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE $100 million Strategic Transaction Closed Plans to Submit New Drug Application for Ifetroban in DMD Top-Line Results Announced for Systemic Sclerosis Trial NASHVILLE, Tenn. (Nov. 10, 2026) – Cumberland